{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T20:29:15Z","timestamp":1722198555184},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","medical.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.mcna.2015.06.001","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T09:08:41Z","timestamp":1441098521000},"page":"1167-1182","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Topical Therapy Primer for Nondermatologists"],"prefix":"10.1016","volume":"99","author":[{"given":"Jolene R.","family":"Jewell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2 Pt 1","key":"10.1016\/j.mcna.2015.06.001_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0190-9622(96)90319-9","article-title":"The pattern of topical corticosteroid prescribing in the United States, 1989\u20131991","volume":"35","author":"Stern","year":"1996","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.mcna.2015.06.001_bib2","first-page":"786","article-title":"Dermatologists' knowledge of and preferences regarding topical steroids","volume":"12","author":"Sandoval","year":"2013","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.mcna.2015.06.001_bib3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.4103\/2229-5178.142483","article-title":"Side-effects of topical steroids: a long overdue revisit","volume":"5","author":"Coondoo","year":"2014","journal-title":"Indian Dermatol Online J"},{"issue":"12","key":"10.1016\/j.mcna.2015.06.001_bib4","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/jama.1996.03540120050033","article-title":"Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs bacitracin ointment. A randomized controlled trial","volume":"276","author":"Smack","year":"1996","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.mcna.2015.06.001_bib5","first-page":"1358","article-title":"Antibiotic resistance: shifting the paradigm in topical acne treatment","volume":"13","author":"Andriessen","year":"2014","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.mcna.2015.06.001_bib6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMc1408272","article-title":"Methemoglobinemia as a complication of topical dapsone","volume":"372","author":"Swartzentruber","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.mcna.2015.06.001_bib7","first-page":"1380","article-title":"Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials","volume":"13","author":"Stein Gold","year":"2014","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.mcna.2015.06.001_bib8","first-page":"33","article-title":"Optimizing the use of topical brimonidine in rosacea management: panel recommendations","volume":"14","author":"Tanghetti","year":"2015","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.mcna.2015.06.001_bib9","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2133.2011.10473.x","article-title":"Effective and evidence-based management strategies for rosacea: summary of a Cochrane systematic review","volume":"165","author":"van Zuuren","year":"2011","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.mcna.2015.06.001_bib10","doi-asserted-by":"crossref","first-page":"965.e1","DOI":"10.1016\/j.jaad.2013.12.045","article-title":"Topical pharmacotherapy for skin cancer: part I. Pharmacology","volume":"70","author":"Micali","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.mcna.2015.06.001_bib11","doi-asserted-by":"crossref","first-page":"979.e1","DOI":"10.1016\/j.jaad.2013.12.037","article-title":"Topical pharmacotherapy for skin cancer: part II. Clinical applications","volume":"70","author":"Micali","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.mcna.2015.06.001_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/DER.0000000000000097","article-title":"North American contact dermatitis group patch test results: 2011\u20132012","volume":"26","author":"Warshaw","year":"2015","journal-title":"Dermatitis"},{"issue":"4 Suppl","key":"10.1016\/j.mcna.2015.06.001_bib13","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2000.109071","article-title":"Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis","volume":"43","author":"Gupta","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.mcna.2015.06.001_bib14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jaad.2012.10.013","article-title":"Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studies","volume":"68","author":"Elewski","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712515001005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712515001005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T16:31:05Z","timestamp":1537374665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712515001005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0025712515001005"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2015.06.001","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical Therapy Primer for Nondermatologists","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2015.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}